SpineGuard is a public company listed on the NYSE Alternext (ticker: ALSGD) in Paris since April 29, 2013. Pierre Jérôme and Stéphane Bette founded the company in January 2009 with the aim to fully exploit the great clinical and market potential of PediGuard, the first and only handheld device capable of alerting surgeons in real time to potential pedicular or vertebral breaches.
The original inventors of the technology, Ciaran Bolger, MD PhD and Maurice Bourlion, PhD are also part of the endeavor, as well as Randal R. Betz, MD, leader of SpineGuard’s international clinical study group. Alan Olsen, the founder of ...
SpineGuard is a public company listed on the NYSE Alternext (ticker: ALSGD) in Paris since April 29, 2013. Pierre Jérôme and Stéphane Bette founded the company in January 2009 with the aim to fully exploit the great clinical and market potential of PediGuard, the first and only handheld device capable of alerting surgeons in real time to potential pedicular or vertebral breaches.
The original inventors of the technology, Ciaran Bolger, MD PhD and Maurice Bourlion, PhD are also part of the endeavor, as well as Randal R. Betz, MD, leader of SpineGuard’s international clinical study group. Alan Olsen, the founder of Danek Medical Inc., now Medtronic Spine, was elected as SpineGuard’s Chairman in May 2010.
Omnes Capital, IPSA, A Plus Finance and Delta Partners are the four historical financial investors of the company.
-
Number of Employees:
0-25
-
Annual Revenue:
$0-1 Million